ACTIVE

PHARMOPSIS

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

4,6 k €

-78.4% YoY

Gross margin

39,9 k €

-27.1% YoY

Equity

626,2 k €

+0.7% YoY

What does PHARMOPSIS do?

PHARMOPSIS is a Private limited company incorporated in 2008. Its main activity is: Management consultancy activities. Its registered office is in Antwerpen.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0896.277.228

Incorporation

07/03/2008

Legal form

Private limited company

Registered office

Entrepotkaai 2 box 801
2000 Antwerpen · FlandreSee on map

Contributed capital

2 000,00 €

Latest accounts

31/12/2024

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	39,9 k €	-27.1%	54,7 k €	-64.4%	153,4 k €	+20.5%	127,3 k €	+24.2%	102,5 k €	-48.6%	199,4 k €	+37.8%	144,7 k €	+112%	68,2 k €	-55.7%	154,2 k €	+109%	73,9 k €	+239%	21,8 k €	-52.5%	45,9 k €	-39.9%	76,4 k €	-1.5%	77,5 k €	+5.1%	73,7 k €	+1236%	5,5 k €
EBITDA	39,3 k €	-27.8%	54,5 k €	-64.5%	153,3 k €	+20.7%	127 k €	+24.9%	101,7 k €	-48.8%	198,4 k €	+37.9%	143,9 k €	+118%	65,9 k €	-56.4%	151,1 k €	+118%	69,2 k €	+231%	20,9 k €	-52.0%	43,5 k €	-41.4%	74,4 k €	-2.7%	76,4 k €	+7.0%	71,4 k €	+1479%	4,5 k €
Operating result	25,8 k €	-45.4%	47,3 k €	-66.7%	141,8 k €	+27.0%	111,7 k €	+17.0%	95,4 k €	-51.8%	198,1 k €	+37.9%	143,7 k €	+119%	65,6 k €	-56.5%	150,9 k €	+129%	66 k €	+313%	16 k €	-59.5%	39,4 k €	-43.7%	70 k €	-3.9%	72,8 k €	+7.0%	68,1 k €	+3981%	1,7 k €
Net result	4,6 k €	-78.4%	21,3 k €	-77.1%	93,2 k €	+36.4%	68,3 k €	+22.8%	55,6 k €	-62.3%	147,8 k €	+32.7%	111,4 k €	+165%	-171,9 k €	-242%	121 k €	+184%	42,7 k €	+257%	11,9 k €	-46.3%	22,2 k €	-48.1%	42,8 k €	-12.9%	49,2 k €	-23.1%	63,9 k €	+27925%	228 €
Balance sheet
Equity	626,2 k €	+0.7%	621,6 k €	+0.8%	616,9 k €	+17.8%	523,7 k €	+15.0%	455,4 k €	+13.9%	399,8 k €	+58.6%	252 k €	+79.2%	140,6 k €	-55.0%	312,5 k €	+63.2%	191,5 k €	+28.7%	148,8 k €	+8.7%	136,9 k €	+19.4%	114,7 k €	+59.5%	71,9 k €	+216%	22,7 k €	+20.7%	18,8 k €
Total assets	689,2 k €	+7.2%	643,1 k €	-12.2%	732,4 k €	+19.8%	611,5 k €	-3.1%	631,1 k €	+32.7%	475,6 k €	+61.1%	295,2 k €	+45.3%	203,2 k €	-53.8%	439,7 k €	+44.8%	303,8 k €	+5.1%	289,1 k €	-5.7%	306,6 k €	-17.8%	372,9 k €	+197%	125,4 k €	-22.6%	162,1 k €	+123%	72,6 k €
Cash	19,3 k €	-20.3%	24,2 k €	-52.1%	50,4 k €	-13.4%	58,2 k €	-60.8%	148,6 k €	-30.4%	213,7 k €	+44.9%	147,5 k €	+32.5%	111,3 k €	-1.4%	112,9 k €	+329%	26,3 k €	-0.9%	26,6 k €	-23.2%	34,6 k €	-65.8%	101,2 k €	-6.7%	108,4 k €	+21.3%	89,4 k €	+337%	20,5 k €
Debts	62,7 k €	+192%	21,5 k €	-81.4%	115,5 k €	+31.6%	87,8 k €	-50.1%	175,7 k €	+132%	75,9 k €	+75.6%	43,2 k €	-31.0%	62,6 k €	-50.8%	127,2 k €	+13.3%	112,3 k €	-19.7%	139,8 k €	-16.7%	167,9 k €	-34.5%	256,4 k €	+406%	50,7 k €	-28.7%	71,1 k €	+32.3%	53,8 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 1 ended

Active mandates

Jan Hoflack

Director

Active

Ended mandates

Jan Hoflack

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Aristotl● Active	1018.326.784
BB Ventures● Active	1028.080.927
BERT WEEMAES● Active	0537.167.687
Broekhoven en Truyens Logistics● Bankrupt	0763.533.916
EDDY RUSSO● Active	0832.860.905
FOENKEL● Active	0768.292.854
ILHOTA INVEST & CONSULT● Active	1000.396.434
LUDWIG CALUWE● Active	0479.559.783
Spotlight-Antwerp● Bankrupt	0749.683.504
VDW NEXUS● Active	1017.915.723

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/09/2025	26/09/2024	29/09/2023	14/09/2022	20/09/2021	06/11/2020
General meeting	02/05/2025	03/05/2024	05/05/2023	06/05/2022	07/05/2021	04/05/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	02/05/2025	30/09/2025	Dutch	PDF
Micro model	31/12/2023	03/05/2024	26/09/2024	Dutch	PDF
Micro model	31/12/2022	05/05/2023	29/09/2023	Dutch	PDF
Micro model	31/12/2021	06/05/2022	14/09/2022	Dutch	PDF
Micro model	31/12/2020	07/05/2021	20/09/2021	Dutch	PDF
Micro model	31/12/2019	04/05/2020	06/11/2020	Dutch	PDF
Micro model	31/12/2018	28/06/2019	29/08/2019	Dutch	PDF
Micro model	31/12/2017	29/06/2018	25/09/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	24/08/2017	Dutch	PDF
Abridged model	31/12/2015	28/06/2016	12/08/2016	Dutch	PDF
Abridged model	31/12/2014	02/05/2015	26/05/2016	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	11/07/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	31/07/2013	Dutch	PDF
Abridged model	31/12/2011	04/05/2012	04/06/2012	Dutch	PDF
Abridged model	31/12/2010	06/05/2011	14/06/2011	Dutch	PDF
Abridged model	31/12/2009	07/05/2010	17/06/2010	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 1 ended

Active mandates

Jan Hoflack

Director

Active

Ended mandates

Jan Hoflack

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates15/09/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Registered office17/05/2021
MAATSCHAPPELIJKE ZETEL
PDF
Registered office02/02/2009
MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
PDF
Other18/03/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 20244,6 k €↓
2023
Annual accounts 202321,3 k €↓
2022
Annual accounts 202293,2 k €↑
2021
Annual accounts 202168,3 k €↑
2020
Annual accounts 202055,6 k €↓
2019
Annual accounts 2019147,8 k €↑
2018
Annual accounts 2018111,4 k €↑
2017
Annual accounts 2017-171,9 k €↓
2016
Annual accounts 2016121 k €↑
2015
Annual accounts 201542,7 k €↑
2014
Annual accounts 201411,9 k €↓
2013
Annual accounts 201322,2 k €↓
2012
Annual accounts 201242,8 k €↓
2011
Annual accounts 201149,2 k €↓
2010
Annual accounts 201063,9 k €↑
2009
Annual accounts 2009228 €
07/03/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMOPSIS

Overview

What does PHARMOPSIS do?

Trend over 16 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline